168 related articles for article (PubMed ID: 9336786)
21. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries.
Lee SW; Trapnell BC; Rade JJ; Virmani R; Dichek DA
Circ Res; 1993 Nov; 73(5):797-807. PubMed ID: 8403251
[TBL] [Abstract][Full Text] [Related]
22. Liver-directed gene transfer in non-human primates.
Sullivan DE; Dash S; Du H; Hiramatsu N; Aydin F; Kolls J; Blanchard J; Baskin G; Gerber MA
Hum Gene Ther; 1997 Jul; 8(10):1195-206. PubMed ID: 9215737
[TBL] [Abstract][Full Text] [Related]
23. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.
Jornot L; Petersen H; Lusky M; Pavirani A; Moix I; Morris ; Rochat T
Endothelium; 2001; 8(3):167-79. PubMed ID: 11824470
[TBL] [Abstract][Full Text] [Related]
24. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
Yang Y; Haecker SE; Su Q; Wilson JM
Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997
[TBL] [Abstract][Full Text] [Related]
25. Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.
Qian HS; Channon K; Neplioueva V; Wang Q; Finer M; Tsui L; George SE; McArthur J
Circ Res; 2001 May; 88(9):911-7. PubMed ID: 11349000
[TBL] [Abstract][Full Text] [Related]
26. Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors.
Schneider DB; Sassani AB; Vassalli G; Driscoll RM; Dichek DA
J Vasc Surg; 1999 Mar; 29(3):543-50. PubMed ID: 10069919
[TBL] [Abstract][Full Text] [Related]
27. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
[TBL] [Abstract][Full Text] [Related]
28. Persistence in muscle of an adenoviral vector that lacks all viral genes.
Chen HH; Mack LM; Kelly R; Ontell M; Kochanek S; Clemens PR
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1645-50. PubMed ID: 9050832
[TBL] [Abstract][Full Text] [Related]
29. TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung.
Minter RM; Rectenwald JE; Fukuzuka K; Tannahill CL; La Face D; Tsai V; Ahmed I; Hutchins E; Moyer R; Copeland EM; Moldawer LL
J Immunol; 2000 Jan; 164(1):443-51. PubMed ID: 10605041
[TBL] [Abstract][Full Text] [Related]
30. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer.
Vilquin JT; Guérette B; Kinoshita I; Roy B; Goulet M; Gravel C; Roy R; Tremblay JP
Hum Gene Ther; 1995 Nov; 6(11):1391-401. PubMed ID: 8573612
[TBL] [Abstract][Full Text] [Related]
31. Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.
Rivera AA; Wang M; Suzuki K; Uil TG; Krasnykh V; Curiel DT; Nettelbeck DM
Virology; 2004 Mar; 320(1):121-34. PubMed ID: 15003868
[TBL] [Abstract][Full Text] [Related]
32. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.
Gahéry-Ségard H; Molinier-Frenkel V; Le Boulaire C; Saulnier P; Opolon P; Lengagne R; Gautier E; Le Cesne A; Zitvogel L; Venet A; Schatz C; Courtney M; Le Chevalier T; Tursz T; Guillet JG; Farace F
J Clin Invest; 1997 Nov; 100(9):2218-26. PubMed ID: 9410899
[TBL] [Abstract][Full Text] [Related]
33. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors.
French BA; Mazur W; Geske RS; Bolli R
Circulation; 1994 Nov; 90(5):2414-24. PubMed ID: 7525108
[TBL] [Abstract][Full Text] [Related]
34. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.
Clemens PR; Kochanek S; Sunada Y; Chan S; Chen HH; Campbell KP; Caskey CT
Gene Ther; 1996 Nov; 3(11):965-72. PubMed ID: 8940636
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated gene transfer into rat cardiac allografts. Comparison of direct injection and perfusion.
Wang J; Ma Y; Knechtle SJ
Transplantation; 1996 Jun; 61(12):1726-9. PubMed ID: 8685951
[TBL] [Abstract][Full Text] [Related]
36. Engineering tissue-specific expression of a recombinant adenovirus: selective transgene transcription in the pancreas using the amylase promoter.
Dematteo RP; McClane SJ; Fisher K; Yeh H; Chu G; Burke C; Raper SE
J Surg Res; 1997 Oct; 72(2):155-61. PubMed ID: 9356237
[TBL] [Abstract][Full Text] [Related]
37. Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo.
Brough DE; Hsu C; Kulesa VA; Lee GM; Cantolupo LJ; Lizonova A; Kovesdi I
J Virol; 1997 Dec; 71(12):9206-13. PubMed ID: 9371579
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
Song W; Kong HL; Traktman P; Crystal RG
Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
[TBL] [Abstract][Full Text] [Related]
39. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response.
Gilgenkrantz H; Duboc D; Juillard V; Couton D; Pavirani A; Guillet JG; Briand P; Kahn A
Hum Gene Ther; 1995 Oct; 6(10):1265-74. PubMed ID: 8590730
[TBL] [Abstract][Full Text] [Related]
40. Adenoviral transfection of isolated pancreatic islets: a study of programmed cell death (apoptosis) and islet function.
Weber M; Deng S; Kucher T; Shaked A; Ketchum RJ; Brayman KL
J Surg Res; 1997 Apr; 69(1):23-32. PubMed ID: 9202642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
